Lusutrombopag (Mulpleta)

From HemOnc.org - A Hematology Oncology Wiki

Revision as of 19:14, 9 June 2023 by Jwarner (talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Mechanism of action

Thrombopoietin receptor agonist

Diseases for which it is used

Thrombocytopenia in liver disease

History of changes in FDA indication

2018-07-31: Approved for thrombocytopenia in adults with chronic liver disease who are scheduled to undergo a medical or dental procedure.

History of changes in PMDA indication

2015-09-28: New approval for the improvement of thrombocytopenia in patients with chronic liver disease for whom an elective invasive procedure is planned.

Also known as

Brand name: Mulpleo, Mulpleta

Retrieved from "https://hemonc.org/w/index.php?title=Lusutrombopag_(Mulpleta)&oldid=72796"